id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0800-0028,FDA,FDA-2011-D-0800,Regulatory Classification of Pharmaceutical Co-Crystals; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2016-08-17T04:00:00Z,2016,8,2016-08-17T04:00:00Z,2016-10-18T03:59:59Z,2016-10-18T01:00:43Z,2016-19596,0,0,090000648217ce04
FDA-2011-D-0800-0029,FDA,FDA-2011-D-0800,Draft Guidance Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry,Other,Guidance,2016-08-17T04:00:00Z,2016,8,2016-08-17T04:00:00Z,,2019-08-20T19:18:35Z,,0,0,090000648217d7dd